SCOUT· 44%40m·2026-08-17·TechnologyEP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
This episode was recorded live from the Ai4 conference podcast pavilion, Sam sat down with Alex Zhavoronkov, Founder & CEO of Insilico Medicine, about what it actually takes to turn AI-generated molecules into approved drugs. What's Covered: From Laughed-Out-of-the-Room to 33 Candidates — Alex pitched generative AI…
Scout bees are checking it out — divided opinions, the swarm hasn't committed.
- Platform
- 44%
- Community
- no read yet
- Value
- no read yet
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
What people are saying
“Nada de curar el envejecimiento”
“Very insightful conversion on AI in drug discovery space.”
“This is definitely a timely conversion about how AI revolutionizing the healthcare space by influencing drug discovery in the longevity therapeutic area.”
More from Inside AsembleAI: DeepTech, AI & Science
See all episodes →
66%EP 57: Ai4 Podcast - Why "The Context Layer" Is What Enterprise AI Is Actually Missing | Andrei Manolache, Designverse
65%EP 56: Ai4 Podcast - Why AI-Generated Code Needs Its Own Kind of Security | Anand Revashetti, Lineaje
55%Ep 55: Ai4 Podcast - Turning 35 Years of Paper Archives into AI Training Data | Dilo Wijesuriya, ARC
Similar episodes from other shows
More like Inside AsembleAI: DeepTech, AI & Science →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
#134 Alex Zhavoronkov: Unraveling AI's Crucial Role in Pharma
🔬 The Coolest Diffusion Research Isn't in LLMs — Evan Feinberg & Sergey Edunov, Genesis Molecular AI
EP 155: AI's Edge in Pharma - Lowering Drug Failure Rates
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.